// App-Quantinova.ai

THU0244 : 3 YEAR FOLLOW UP OF AN AT-RISK CONNECTIVE TISSUE DISEASE COHORT: ANALYSIS OF CLINICAL, GENE EXPRESSION AND FLOW CYTOMETRIC BIOMARKERS

Researchers

Presenter

  • S. U. Hassan

Principal Investigators

  • Z. Wigston

  • A. Psarras

  • K. Dutton

  • M. Y. MD Yusof

  • E. Vital

Medical Centers

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • IFN-lambda

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • AstraZeneca.

Result

  • N/A